As a regular feature of our annual forecast issue, IBO selects a firm from our industry as “company of the year.” In designating the company of the year, IBO recognizes an analytical and life science instrument maker that has accomplished technical, operational and financial achievements. Such achievements are a function of strong financial performance, market […]
Washington, DC 1/14/14; San Francisco, CA 1/14/14—During its presentation at the J.P. Morgan Healthcare Conference, Illumina announced its financial guidance for 2014 and made announcements regarding its sequencing and diagnostics businesses. For 2014, the company forecast revenues to grow 15%–17% and non-GAAP diluted EPS to be $2.00–$2.06. Gross margins are expected to be 70%. The […]
Not to be confused with next generation sequencers (NGS), gene mapping systems are another tool for analyzing DNA molecules. Gene mapping systems are not as detailed as NGS systems, but instead provide information about where certain sequences appear on a chromosome. They provide information complementary to NGS results. The information that gene mapping systems provide […]
Company Announcements Consumer DNA firm Gene by Gene acquired sequencing data management firm Arpeggi in August. Illumina partnered with Global Genomics Group to investigate novel biomarkers and biological pathways involved in the development and diagnosis of cardiovascular diseases. Illumina will conduct whole-genome sequencing as part of a pan-omic study. In September, Illumina applied the EU’s […]
Molecular cytogenetic technologies have become vitally important in the analysis of chromosomes for both diagnostics and research applications. Technologies such as fluorescent in situ hybridization (FISH) and microarrays are replacing traditional karyotyping. FISH uses fluorescent probes that bind to the complementary DNA sequence on a chromosome. The samples are typically placed on a glass slide, […]
Branford, CT 10/3/13—According to multiple media reports, Roche will close its 454 Life Sciences subsidiary, which provides DNA sequencers. The New Haven Register reported that the company will shut down by the end of 2015. Manufacturing will cease in 2015 and the sequencers will be phased-out by mid-2016, at which time the company will no […]
Company Announcements Helicos BioSciences licensed its intellectual property to Complete Genomics, Fluidigm, Illumina and Life Technologies. In September, Life Technologies introduced the Ion AmpliSeq Exome Certified Service Provider program. Life Technologies named TriCore Reference Laboratories a regional Next Generation Sequencing (NGS) Center of Excellence. The NIH National Human Genome Research Institute awarded a research consortium […]
Next generation sequencers (NGS) revolutionized the market for DNA analysis. However, the instruments’ cost has traditionally been a limiting factor for many laboratories to acquire and utilize the technology on their own bench. Instead, scientists would have to send their samples to core facilities to have them sequenced. Personal DNA sequencers are the next iteration […]
Company Announcements Trovagene entered into a research agreement in June with Illumina to evaluate integrating their respective transrenal and sequencing technologies. The CEO of Life Technologies’ Ion Torrent business, Dr. Jonathan Rothberg, resigned in June. Ronnie Andrews, president of the Genetic and Medical Sciences organization, now oversees the business. Sage Science named Uniscience do Brasil […]
Beverly, MA and Boulder, CO 9/6/13—Enzymatics, a producer of reagents, kits and assays, has acquired ArcherDx, a developer of kits and software for next generation sequencing (NGS) for use in investigating cancer treatments, for cash, equity and potential milestones worth up to $50 million. Enzymatics stated that the acquisition expands its Enzymatics Diagnostics group, adding […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
